Cord Blood Company Reducing Debt

According to a recently released press statement, Cord Blood America is reducing its debt via acquisition of superior, outside loans.

This progress may be indicative of the umbilical cord blood industry's relative soundness. With banking increasing and additional attention being paid to cord blood and its powerful medical potential, there is every reason to believe that good companies in the banking field will prosper.

I don't have a great deal of personal knowledge about Cord Blood America and won't make any predictions regarding its viability. The information provided in the press release, if accurate, does appear to be quite positive.

Here's an excerpt:
"Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry."